is tirzepatide fda approved for weight loss RxConnection FDA approves new weight-loss drug

The medication works through activation of both GIP and GLP-1 receptors, which are incretin hormones naturally produced in the gastrointestinal tract

Clinical evidence from the SURMOUNT-4 randomized withdrawal study indicates that patients typically regain a substantial portion of lost weight after discontinuation

Exception: protein shakes

For those on semaglutide who want equivalent conversion charts and dosing references, we maintain comprehensive guides for semaglutide 5 mg/mL dosage charts , semaglutide mixing charts , and semaglutide syringe dosage conversion charts

Denied Appeal with your provider or switch to compounded tirzepatide (no PA required)